20 "Past Their Prime" Stocks to Dump From Your Portfolio - 16 of 20

Slide 16

Roivant Sciences (NASDAQ:ROIV)

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. Read More

Current Stock Price: $12.69
P/E Ratio: 2.2
Consensus Rating: Moderate Buy
Ratings Breakdown: 7 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $17.93 (41.3% Upside)

Slide 16

Back to 15

Continue to 17

The latest trend in real estate (Ad)

These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.

Don’t miss your chance to maximize your stake in this co-ownership revolution.

More From MarketBeat

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

20 "Past Their Prime" Stocks to Dump From Your Portfolio - 16 of 20

Roivant Sciences (NASDAQ:ROIV)

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

20 "Past Their Prime" Stocks to Dump From Your Portfolio - 16 of 20

Roivant Sciences (NASDAQ:ROIV)

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools